Menu
Log In Sign Up
Article

cyclic depsipeptides one or more amide, -C(O)NHR-, linkages are replaced by the corresponding ester, -C(O)OR

Published October Oct 18, 2026 3:25 AM

In the realm of advanced biochemistry and peptide research, few molecular architectures are as fascinating as cyclic depsipeptides. As someone who has spent years exploring the nuances of specialized peptide chemistry, I have found that these compounds represent a unique intersection of structural stability and functional diversity.

Defining the Architecture: What Are Cyclic Depsipeptides?

At their core, cyclic depsipeptides (CDPs) are defined as a family of cyclic peptide-related compounds. Unlike standard peptides, which are characterized by amide linkages, a depsipeptide is a molecule where one or more amide, -C(O)NHR-, linkages are replaced by the corresponding ester, -C(O)OR- linkages.

Essentially, they are polypeptides in which one or more amino acid is replaced by a hydroxy acid, resulting in the formation of at least one ester bond. This specific structural modification creates a cyclic structure where the loop is closed by an ester/lactone group. This leads to a distinct category of nonribosomal peptides cyclized via an ester bond, often containing non-proteinogenic amino acids. From my experience in the laboratory, this modification is n Jul 17, 2024 — In conclusion, we have discovered wajeepeptin (1), a novel cyclic depsipeptide containing a β-amino acid residue (Map), from a marine Moorena sp  ot merely cosmetic; it fundamentally alters the molecule's interaction with its environment.

Why Structural Stability Matters

When evaluating these compounds, one must consider their enhanced structural stability, target specificity, and therapeutic potential. Because they are essentially polypeptide chains that are formed by a cyclic sequence of 5 to 14 amino acids, they possess a rigid geometry that linear counterparts lack.

In my review of various cyclic peptides, I have noted that the presence of the ester bond provid Cyclic Peptides: Current Status & Future Prospects es a unique conformational constraint. Whether we are discussing cyclic lipodepsipeptides—which integrate into membranes—or cyclic carbo-isosteric depsipeptides, the inclusion of hydroxy acids creates peptides in which amide groups are replaced by corresponding ester linkages. This variation allows them to mimic natural ligands while resisting rapid degradation, a hallmark of their utility in advanced chemical research.

Biological Diversity and Applications

The diversity within this family is staggering. Cyclodepsipeptides show a broad spectrum of biological activities, ranging from antiviral and antifungal properties to roles as immunosuppressants. For instance, Rakicidin F is a cyclic depsipeptide that utilizes a hydrophobic tail to facilitate integration into bacterial cell membranes.

Similarly, researchers have identified a novel cyclic depsipeptide like wajeepeptin, derived from ma by PA Trinidad-Calderón · 2023 · Cited by 10 — These cyclic depsipeptides, comprising a macrocyclic carbon skeleton and six amino acid-derived moieties [21], were originally derived from the sea slug  rine organisms. These bioactive compounds of medical and industrial importance are often isolated from complex natural sources like cyanobacteria. It is also worth noting the discovery of YM-280193, a cyclic depsipeptide that has been studied for its unique ability to modulate platelet aggregation.

Dec 5, 2025 — Cyclic peptides offer enhanced structural stability, target specificity, and therapeutic potential compared to linear peptides.

Key Insights for Researchers

If you are investigating this field, keep these po Structural and functional studies of cyclic depsipeptide ints in mind:

* Composition: They are a large family By surface analysis, cyclo- +‎ depsi- +‎ peptide. Noun. cyclodepsipeptide (plural cyclodepsipeptides). (organic chemistry) Any cyclic depsipeptide. of peptide-related natural product Genetically programmed cell-based synthesis of non- s consisting of hydroxy a Jan 15, 2015 — The first total synthesis of YM-280193, a cyclic depsipeptide that inhibits the ADP-induced aggregation of human platelets, is described. nd amino acids.

* Synthesis: While traditionally sourced from nature, there is significant interest in the total synthesis of cyclic depsipeptides. The challenge lies in the precise formation of the ester/lactone bond within the polypeptide chains composed of canonical and non-canonical amino acids.

* Functionality: Whether you are looking at cyclic peptides or specifically cyclodepsipeptides, the primary draw is their ability to act as polypeptide chains which contain a circular sequence of bonds.

These molecules represent a sophisticated frontier in chemical biology. By replacing standard peptide bonds with ester linkages, nature—and now synthetic chemists—can create peptides that contain one or more ester bonds in addition to the amide bonds. This structural shift is what makes them such a potent area of study for anyone interested in the future of improving treatments for cancer, inflammatory and infectious diseases.

As with any complex depsipeptide, understanding the interplay between the macrocyclic carbon skeleton and the amino acid-derived moieties is essential for unlocking their full potential in experimental settings.

Leave a Comment
Get new articles in your inbox

News, updates and freebies. No spam, unsubscribe anytime.